Foresite Capital Management IV as of March 31, 2024
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 5 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 47.2 | $93M | 4.0M | 23.11 | |
| Kura Oncology (KURA) | 19.9 | $40M | 1.8M | 21.33 | |
| Kinnate Biopharma | 13.0 | $26M | 9.7M | 2.66 | |
| Syndax Pharmaceuticals (SNDX) | 10.5 | $21M | 875k | 23.80 | |
| Lyell Immunopharma (LYEL) | 9.4 | $19M | 8.3M | 2.23 |
